The bill amends West Virginia Code §30-5-10 to expand the scope of practice for licensed pharmacists. It authorizes pharmacists to prescribe certain non-controlled drugs in accordance with FDA-approved labeling, specifically for conditions that can be tested using waived laboratory tests for influenza, SARS-COV-2, and RSV, or for refilling expired prescriptions for epinephrine injection devices. Additionally, the bill requires pharmacists to notify the patient's primary care physician within 72 hours of the test results and the prescribed medication. Furthermore, any prescription dispensed or prescribed under this new provision is limited to a 30-day supply within a six-month period, with additional notification requirements if more than 10 days is prescribed.

The legislation also includes provisions for pharmacists to administer immunizations, provided they meet specific requirements set by legislative rule. It maintains existing regulations regarding the sale of potentially harmful medicines, ensuring that only registered pharmacists can sell such products while informing purchasers of their nature. This bill is set to take effect 90 days after its passage, on July 11, 2025.

Statutes affected:
Introduced Version: 30-5A-1, 30-5A-2, 30-5A-3
Committee Substitute: 30-5A-1, 30-5A-2, 30-5A-3, 30-5A-4
Engrossed Committee Substitute: 30-5A-1, 30-5A-2, 30-5A-3, 30-5A-4
Enrolled Committee Substitute: 30-5-10